Revenue
$502.7M
▲ 27.8% YoY
Net Income
-$60.6M
▲ 6.3% YoY
EPS
$-0.54
▲ 23.9% YoY
Cash
$33.6M
▼ 32.4% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Podnos Yale Chief Medical Officer | Sell | Jun 8, 2026 | 23.5K | $5.38 | $126K | Form 4 ↗ |
Chernett Jorey | Buy | Jun 4, 2026 | 12.0K | $4.75 | $57K | Form 4 ↗ |
Podnos Yale Chief Medical Officer | Sell | May 21, 2026 | 1.8K | $4.47 | $8K | Form 4 ↗ |
Virnich Daniel Chief Executive Officer | Sell | May 21, 2026 | 23.1K | $4.47 | $103K | Form 4 ↗ |
Carter Robert Ross Chief Financial Officer | Sell | May 21, 2026 | 1.6K | $4.47 | $7K | Form 4 ↗ |
Chernett Jorey | Buy | May 20, 2026 | 33.5K | $4.07 | $136K | Form 4 ↗ |
Chernett Jorey | Buy | May 19, 2026 | 5.0K | $4.05 | $20K | Form 4 ↗ |
Chernett Jorey | Buy | May 19, 2026 | 30.0K | $4.09 | $123K | Form 4 ↗ |
Kaushal Mohit | Sell | Apr 16, 2026 | 38.4K | $3.50 | $135K | Form 4 ↗ |
Kaushal Mohit | Sell | Apr 14, 2026 | 57.3K | $3.50 | $201K | Form 4 ↗ |
Chernett Jorey | Buy | Apr 9, 2026 | 20.0K | $3.10 | $62K | Form 4 ↗ |
Langsam Jeffrey Chief Clinical Officer | Grant | Mar 27, 2026 | 70.3K | $0.00 | $0 | Form 4 ↗ |